RecruitingNCT06338943

Middle-aged Women With Adverse Pregnancy Outcomes and Heart Failure With Preserved Ejection Fraction


Sponsor

National Medical Research Center for Therapy and Preventive Medicine

Enrollment

100 participants

Start Date

Mar 18, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Due to the steady increase in the burden of HFpEF, especially in women, it is an important task to search for new markers and early predictors associated with the development of this disease. Nowadays, the relationship of adverse pregnancy factors with the development of long-term cardiac pathology, in particular, HFpEF, has not been completely established. One of the most significant issue is studying the younger phenotype of women. The goal of this observational analytical cross-sectional study is to study the relationship of heart failure with a preserved ejection fraction in middle-aged women with adverse pregnancy outcomes in the history of pregnancy. Research question: is there an association between adverse pregnancy factors and the development of HF in middle-aged women? Objectives 1. To assess the frequency of detection of APOs in the history of pregnancy in middle-aged women, depending on the presence or absence of HFpEF. 2. To compare clinical and anamnestic data, morphological and functional parameters of the heart in middle-aged women with the presence and absence of HFpEF. 3. To establish an association between APOs and the development of HFpEF in the long-term period in middle-aged women. 4. To identify mediators between the presence of APOs and the development of HFpEF in middle-aged women. Study population - 45-60 year-old women with the history of pregnancy (\>20 weeks) in the absence of low left ventricle ejection fraction (\<50%) Primary endpoint: The prevalence of HFpEF in patients with the history of APOs.


Eligibility

Sex: FEMALEMin Age: 45 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study examines the connection between having had a complicated pregnancy (such as preeclampsia — dangerously high blood pressure during pregnancy) and developing heart failure with preserved ejection fraction (HFpEF — a type of heart stiffness) in middle-aged women. **You may be eligible if...** - You are a woman who has had a pregnancy lasting more than 20 weeks - You are receiving an echocardiogram (heart ultrasound) at the participating medical center for medical reasons - You are willing to sign the informed consent form **You may NOT be eligible if...** - You refuse to sign the consent form - Your echocardiogram shows that your heart's pumping function (ejection fraction) is less than 50% Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTEchocardiography

Echocardiography to diagnose HFpEF

OTHERQuestionnaire

Questionnaire to determine the presence of adverse pregnancy outcomes history


Locations(1)

National Medical Research Center for Therapy and Preventive Medicine

Moscow, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06338943


Related Trials